Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Intramyocardial injected human umbilical cord-derived mesenchymal stem cells (HucMSCs) contribute to the recovery of cardiac function and the migration of CD4+ T cells into the infarcted heart via CCL5/CCR5 signaling

Fig. 5Fig. 5

Increase of immune cells in the infarcted heart after HucMSCs treatment on day 7. A Representative immunofluorescence images of hearts stained with human mitochondrion and CD3/CD4 in MI-HucMSC groups. Green, HucMSCs; Red, CD3; Blue, DAPI. Scale bar = 50 µm. B Representative immunofluorescence images of hearts stained with CD3 and CD4 between MI-N.S and MI-HucMSC groups. Green, CD3; Red, CD4; Blue, DAPI. Scale bar = 75 µm. C Representative immunofluorescence images of hearts stained with CD4 and Ki67 between MI-N.S and MI-HucMSC groups. Red, CD4; Green, Ki67; Blue, DAPI. Yellow arrow indicates CD4+Ki67+ double positive cells. Scale bar = 75 µm. D Representative immunofluorescence images of hearts stained with CD4 and FoxP3 between MI-N.S and MI-HucMSC groups. Green, CD4; Red, FoxP3; Blue, DAPI. Yellow arrow indicates CD4+FoxP3+ double positive cells. Scale bar = 50 µm. E Statistical results of percent (%) of CD3+ or CD4+ T cells between MI-N.S and MI-HucMSC groups. F Statistical results of cell counts of CD4+Ki67+ T cells between MI-N.S and MI-HucMSC groups. G Statistical results of cell counts of CD4+FoxP3+ Tregs between MI-N.S and MI-HucMSC groups. H The flow diagram of the heart digestion and strategy of flow cytometry analysis. I Statistical results of cell counts of immune cells between MI-N.S and MI-HucMSC groups. *p < 0.05 and **p < 0.01 versus MI-N.S group

Back to article page